1. Home
  2. HOWL vs MGLD Comparison

HOWL vs MGLD Comparison

Compare HOWL & MGLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HOWL
  • MGLD
  • Stock Information
  • Founded
  • HOWL 2017
  • MGLD 1996
  • Country
  • HOWL United States
  • MGLD United States
  • Employees
  • HOWL N/A
  • MGLD N/A
  • Industry
  • HOWL Biotechnology: Pharmaceutical Preparations
  • MGLD Finance/Investors Services
  • Sector
  • HOWL Health Care
  • MGLD Finance
  • Exchange
  • HOWL Nasdaq
  • MGLD Nasdaq
  • Market Cap
  • HOWL 47.1M
  • MGLD 44.8M
  • IPO Year
  • HOWL 2021
  • MGLD N/A
  • Fundamental
  • Price
  • HOWL $1.33
  • MGLD $1.03
  • Analyst Decision
  • HOWL Strong Buy
  • MGLD
  • Analyst Count
  • HOWL 5
  • MGLD 0
  • Target Price
  • HOWL $7.20
  • MGLD N/A
  • AVG Volume (30 Days)
  • HOWL 135.8K
  • MGLD 18.0K
  • Earning Date
  • HOWL 11-06-2025
  • MGLD 11-07-2025
  • Dividend Yield
  • HOWL N/A
  • MGLD N/A
  • EPS Growth
  • HOWL N/A
  • MGLD N/A
  • EPS
  • HOWL N/A
  • MGLD N/A
  • Revenue
  • HOWL N/A
  • MGLD $31,205,000.00
  • Revenue This Year
  • HOWL N/A
  • MGLD N/A
  • Revenue Next Year
  • HOWL N/A
  • MGLD N/A
  • P/E Ratio
  • HOWL N/A
  • MGLD N/A
  • Revenue Growth
  • HOWL N/A
  • MGLD N/A
  • 52 Week Low
  • HOWL $0.60
  • MGLD $0.64
  • 52 Week High
  • HOWL $4.18
  • MGLD $2.10
  • Technical
  • Relative Strength Index (RSI)
  • HOWL 52.75
  • MGLD 58.83
  • Support Level
  • HOWL $1.29
  • MGLD $0.84
  • Resistance Level
  • HOWL $1.40
  • MGLD $1.15
  • Average True Range (ATR)
  • HOWL 0.07
  • MGLD 0.10
  • MACD
  • HOWL 0.00
  • MGLD 0.02
  • Stochastic Oscillator
  • HOWL 61.90
  • MGLD 74.36

About HOWL Werewolf Therapeutics Inc.

Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.

About MGLD The Marygold Companies Inc.

The Marygold Companies Inc is a holding company that intends to focus on financial services. It is currently directing its investments towards financial services and the emerging Fintech space.

Share on Social Networks: